Dipentum is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Olsalazine Sodium.
| Product ID | 68151-0312_75c040b8-d3c3-4df8-adb9-af948f9bc0dd | 
| NDC | 68151-0312 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Dipentum | 
| Generic Name | Olsalazine Sodium | 
| Dosage Form | Capsule, Gelatin Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2015-05-15 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA019715 | 
| Labeler Name | Carilion Materials Management | 
| Substance Name | OLSALAZINE SODIUM | 
| Active Ingredient Strength | 250 mg/1 | 
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2018-12-31 | 
| Marketing Start Date | 2017-12-26 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA019715 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-12-26 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| OLSALAZINE SODIUM | 250 mg/1 | 
| SPL SET ID: | 9dd522a3-587e-44ab-9de3-a0fd079f2ffb | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0037-6860 | Dipentum | olsalazine sodium | 
| 68151-0312 | Dipentum | olsalazine sodium | 
| 68151-3120 | Dipentum | olsalazine sodium | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() DIPENTUM  76481658  not registered Dead/Abandoned  | 
        Celltech Pharmaceuticals, Inc.  2003-01-13  | 
![]() DIPENTUM  76481657  not registered Dead/Abandoned  | 
        Celltech Pharmaceuticals, Inc.  2003-01-13  | 
![]() DIPENTUM  73506342  1337522 Live/Registered  | 
        Pharmacia, Inc.  1984-10-30  |